[1]
Ullah, Z. et al. 2022. Efficacy of Sofosbuvir and Daclatasvir in Achieving the End Treatment Response and Sustained Viral Response in Patients infected with Hepatitis C Virus Genotype 3. Pakistan Armed Forces Medical Journal. 72, 3 (Jun. 2022), 1074–77. DOI:https://doi.org/10.51253/pafmj.v72i3.4470.